Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | GRM8 | O00222 | 1/20 | 0.34 |
| ▸ | GRM6 | O15303 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.34 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28818337 | 1.00 | KMT2A (0.52) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL711607 | 0.87 | ALOX15 (0.60) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL28313344 | 0.87 | ALOX15 (0.60) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL1237866 | 0.85 | ALOX15 (0.48) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL23200441 | 0.84 | CYP1A2 (0.54) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL1606668 | 0.84 | SLC1A1 (0.36) | KMT2AALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL8838342 | 0.84 | CYP1A2 (0.54) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL8128271 | 0.84 | SLC1A1 (0.36) | KMT2AALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL8838340 | 0.84 | SLC1A1 (0.36) | KMT2AALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL7176759 | 0.83 | ALOX15 (0.56) | KMT2AALOX15BLMPMP22DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087109-A1 | PERSONAL CARE COMPOSITION BASED ON AN ACETYL AMINOACID COMPOUND AND A CYSTINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260060912-A1 | SKIN CARE PRODUCT WITH PROTEIN MATRIX | Eighth Day Labs, LLC (US) | 2026-03-05 | — | — | US | claimed |
| US-12496266-B2 | Skin care product with protein matrix | Eighth Day Labs, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-20250152499-A1 | COMPOSITIONS AND METHODS FOR SUPPORTING SKIN BARRIER HOMEOSTASIS | Skinfix Inc. (CA) | 2025-05-15 | — | — | US | claimed |
| US-20250090443-A1 | SKIN CARE COMPOSITIONS AND THEIR USES | Flawless Beauty LLC | 2025-03-20 | — | — | US | claimed |
| US-12201717-B2 | Compositions and methods for supporting skin barrier homeostasis | Skinfix Inc. (CA) | 2025-01-21 | — | — | US | claimed |
| US-20240245596-A1 | SKIN CARE PRODUCT WITH PROTEIN MATRIX | Eighth Day Labs, LLC (US) | 2024-07-25 | — | — | US | claimed |
| WO-2024098078-A2 | COMPOSITIONS AND METHODS FOR SUPPORTING SKIN BARRIER HOMEOSTASIS | Skinfix Inc. (CA) | 2024-05-10 | — | — | WO | claimed |
| US-20240139095-A1 | COMPOSITIONS AND METHODS FOR SUPPORTING SKIN BARRIER HOMEOSTASIS | Skinfix Inc. (CA) | 2024-05-02 | — | — | US | claimed |
| CN-117860601-A | Application of glutaminyl ethyl indole, restorative and skin care product and cosmetic | 熬夜肌实验室系统工程(上海)有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-107582521-A | Good acetyl glutamine injection of a kind of stability and preparation method thereof | 江西省子轩科技有限公司 | 2018-01-16 | — | — | CN | claimed |
| CN-105037195-A | Aceglutamide, and injection and preparation method thereof | KAMP PHARMACEUTICALS CO LTD | 2015-11-11 | — | — | CN | claimed |
| CN-102018668-B | Preparation method of aceglutamide | SHANGHAI ZHAOHUI PHARMACEUTICAL CO LTD | 2012-01-18 | — | — | CN | claimed |
| CN-102018668-A | Preparation method of aceglutamide | SHANGHAI ZHAOHUI PHARMACEUTICAL CO LTD | 2011-04-20 | — | — | CN | claimed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| CN-1830425-A | Preparation method of acetyl glutamine injection | BALIMOER PHARMACEUTICAL TONGHU (CN) | 2006-09-13 | — | — | CN | claimed |
| CN-1444931-A | Aceglutamide injection | ZHANG SONG (CN) | 2003-10-01 | — | — | CN | claimed |
| EP-0957887-A2 | COMPOSITION AND METHOD FOR REDUCING STINGING IN SKIN | E-L Management Corp. (US) | 1999-11-24 | — | — | EP | claimed |
| WO-1999013819-A2 | COMPOSITION AND METHOD FOR REDUCING STINGING IN SKIN | E-L MANAGEMENT CORP. (US) | 1999-03-25 | — | — | WO | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060912-A1 | SKIN CARE PRODUCT WITH PROTEIN MATRIX | CUTA, HGFAC, BHMT | KMT2A 4458/4885ALOX15 2800/4885BLM 4671/4885 |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | KMT2A 756/4885ALOX15 2795/4885BLM 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.